共 95 条
[1]
Gartz M(2021)Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy Hum Mol Genet 30 2347-2361
[2]
Beatka M(2008)Duchenne muscular dystrophy Neurol India 56 236-247
[3]
Prom MJ(2019)CRISPR correction of Duchenne muscular dystrophy Annu Rev Med 70 239-255
[4]
Yiu EM(2010)Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management Lancet Neurol 9 77-93
[5]
Kornberg AJ(2020)Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy Neurology 94 e2270-e2282
[6]
Min YL(2021)Inflammation in Duchenne muscular dystrophy-exploring the role of neutrophils in muscle damage and regeneration Biomedicines 9 1366-791
[7]
Bassel-Duby R(2020)Therapeutic strategies for Duchenne muscular dystrophy: an update Genes (Basel) 11 837-461
[8]
Olson EN(2021)Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy Nat Commun 12 6264-386
[9]
Bushby K(2019)Gene therapy rescues cardiac dysfunction in Duchenne muscular dystrophy mice by elevating cardiomyocyte deoxy-adenosine triphosphate JACC Basic Transl Sci 4 778-1250
[10]
Finkel R(2018)Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study Lancet 391 451-S316